
Renovo Neural Inc. (RNI) is a specialized research organization with a mission of providing niche services that can revolutionize biological research and development of neural therapies, with current focus on multiple sclerosis (MS). RNI has commercialized preclinical assays and advanced 3D-electron microscopy services to provide customized solutions for basic science, preclinical and clinical research, and drug development.